BioMed Central Blog

BioMed Central Publishes Framingham Heart Study 100K Results

BioMed Central has published a series of 17 research articles based on genetic data from the Framingham Heart Study (FHS), as a supplement to BMC Medical Genetics. The collected research, FHS 100K, is the result of cooperation among several research institutions including Boston University School of Medicine and Public Health; the National Heart, Lung and Blood Institute (NHLBI); the National Library of Medicine; and the National Center for Biotechnology Information (NCBI).  

FHS 100K will be given unprecedented availability via BioMed Central's open access journal and through NCBI's Database of Genotypes and Phenotypes (dbGaP). The researchers' decision to publish in BioMed Central's open access journal underlines their collective belief that genetic observations from FHS should be made publicly available and remain an unpatented data resource designed to accelerate scientific discovery.

The aim of the Framingham Heart Study is to identify the common factors or characteristics that contribute to cardiovascular disease (CVD) by following its development over a long period of time in a large group of participants who had not yet developed overt symptoms of CVD or suffered a heart attack or stroke. The data from all of the studies will be made available through NHLBI's dbGaP, a database designed to archive and distribute data from genome wide association studies. Researchers around the world will be able to use the results in the database to conduct further research to create new drugs and treatments to benefit patients.

For more information please see today's press release.

Posted by Charlotte Webber at 12:39    Comments (0)